Literature DB >> 23483548

Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family.

Yu Yu1, Junzhou Wu, Lizhao Guan, Lihua Qi, Yan Tang, Bo Ma, Jun Zhan, Yunling Wang, Weigang Fang, Hongquan Zhang.   

Abstract

Kindlin 2, as a focal adhesion protein, controls integrin activation and regulates Wnt signaling in an integrin-binding independent manner. However, the association of Kindlin 2 with cancer-related microRNAs is unknown. Here, we report that Kindlin 2 markedly downregulates the expression of miR-200 family by inducing CpG island hypermethylation. Mechanistically, Kindlin 2 forms a complex with DNMT3A in the cell nucleus and the two proteins co-occupy the promoter of miRNA-200b. Functionally, repression of miR-200b is required for Kindlin 2-induced breast cancer cell invasion and tumor formation. Our data indicate that Kindlin 2 plays a novel role in epigenetic repression of miR-200 family, a mechanism that promotes breast cancer invasion.
Copyright © 2013 UICC.

Entities:  

Keywords:  DNA methyltransferase; Kindlins; MicroRNA-200 family; breast cancer

Mesh:

Substances:

Year:  2013        PMID: 23483548     DOI: 10.1002/ijc.28151

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

Review 1.  Epigenetic regulation of epithelial-mesenchymal transition.

Authors:  Lidong Sun; Jia Fang
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

2.  Down-regulation of microRNA-200b is a potential prognostic marker of lung cancer in southern-central Chinese population.

Authors:  Wen Li; Ming Xi Jia; Jing Deng; Jian Hui Wang; Qin Lu Lin; Jian Xin Tang; Xiao Xi Zeng; Fang Cai; Liang Ma; Wei Su; Xue Ying Liu; Cun Liu; Sha Sha Wang; Li Yi Zhou
Journal:  Saudi J Biol Sci       Date:  2018-08-31       Impact factor: 4.219

3.  Kindlin-2 Regulates the Growth of Breast Cancer Tumors by Activating CSF-1-Mediated Macrophage Infiltration.

Authors:  Khalid Sossey-Alaoui; Elzbieta Pluskota; Katarzyna Bialkowska; Dorota Szpak; Yvonne Parker; Chevaun D Morrison; Daniel J Lindner; William P Schiemann; Edward F Plow
Journal:  Cancer Res       Date:  2017-07-07       Impact factor: 12.701

4.  Expression of kindlin-3 in melanoma cells impedes cell migration and metastasis.

Authors:  Chen Feng; Wei-Kiat Wee; Huizhi Chen; Li-Teng Ong; Jing Qu; Hui-Foon Tan; Suet-Mien Tan
Journal:  Cell Adh Migr       Date:  2016-11-02       Impact factor: 3.405

5.  YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.

Authors:  Qiqi Cui; Chao Wang; Shuang Liu; Runxuan Du; Shaoping Tian; Ruibing Chen; Hua Geng; Saravanan Subramanian; Yuanjie Niu; Yong Wang; Dan Yue
Journal:  Cell Cycle       Date:  2021-10-28       Impact factor: 4.534

6.  Kindlin-2 promotes Src-mediated tyrosine phosphorylation of androgen receptor and contributes to breast cancer progression.

Authors:  Luyao Ma; Yeteng Tian; Tao Qian; Wenjun Li; Chengmin Liu; Bizhu Chu; Qian Kong; Renwei Cai; Panzhu Bai; Lisha Ma; Yi Deng; Ruijun Tian; Chuanyue Wu; Ying Sun
Journal:  Cell Death Dis       Date:  2022-05-20       Impact factor: 9.685

Review 7.  MiR-200, a new star miRNA in human cancer.

Authors:  Xiangling Feng; Zhengming Wang; Rebecca Fillmore; Yaguang Xi
Journal:  Cancer Lett       Date:  2013-11-19       Impact factor: 8.679

8.  miR-200b as a prognostic factor targets multiple members of RAB family in glioma.

Authors:  Qing Liu; Hailin Tang; Xiaoping Liu; Yiwei Liao; Haoyu Li; Zijin Zhao; Xianrui Yuan; Weixi Jiang
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

Review 9.  Role of Kindlin-2 in cancer progression and metastasis.

Authors:  Wei Wang; Urna Kansakar; Vesna Markovic; Khalid Sossey-Alaoui
Journal:  Ann Transl Med       Date:  2020-07

10.  Kindlin 2 regulates myogenic related factor myogenin via a canonical Wnt signaling in myogenic differentiation.

Authors:  Yu Yu; Lihua Qi; Junzhou Wu; Yunling Wang; Weigang Fang; Hongquan Zhang
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.